Market Cap 53.60B
Revenue (ttm) 70.99B
Net Income (ttm) 4.43B
EPS (ttm) N/A
PE Ratio 9.71
Forward PE 9.41
Profit Margin 6.24%
Debt to Equity Ratio 0.69
Volume 1,169,000
Avg Vol 3,645,498
Day's Range N/A - N/A
Shares Out 658.89M
Stochastic %K 31%
Beta 0.76
Analysts Strong Sell
Price Target $94.31

Company Profile

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance...

Industry: Insurance - Life
Sector: Financial Services
Phone: 212 578 9500
Address:
200 Park Avenue, New York, United States
JediJumps
JediJumps Dec. 24 at 6:40 PM
$MET Long‑horizon outcomes depend on proof that pricing power can persist through normalization phases, with outcomes shaped by timing and discipline. Operational proof points remain decisive.
0 · Reply
JarvisFlow
JarvisFlow Dec. 23 at 2:37 PM
Wells Fargo updates rating for MetLife ( $MET ) to Overweight, target set at 92 → 94.
0 · Reply
1iquid
1iquid Dec. 20 at 12:05 PM
OptionWizards Tip (education only): Set a maximum loss for each options trade on D, PCAR, or MET to manage risk and protect your trading capital. $D $PCAR $MET Not financial advice.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 19 at 3:34 PM
$MET Actionable Trade Alert: Market Context: $MET is currently trading at $81.71, exhibiting strong bullish momentum with an RSI of 77.06, indicating overbought conditions. However, the price is near the 60D high of $83.85, suggesting potential resistance ahead. Directional Bias: The RSI indicates a strong bullish trend, but the proximity to the 60D high may lead to a pullback. The MA30 (77.88) and MA50 (78.57) provide support levels, indicating a potential for price correction before further upward movement. Trade Plan: - Suggested Entry: $81.00 (considering a slight pullback) - Stop Loss: $79.50 (2.5% below entry) - Take Profit Targets: 1. $83.00 (Target 1: 2.5% ROI) 2. $84.50 (Target 2: 4.5% ROI) 3. $95.00 (Target 3: 17% ROI) This trade plan allows for a calculated entry with a favorable risk-reward ratio. Monitor price action closely, especially around resistance levels. https://privateprofiteers.com
0 · Reply
ZacksResearch
ZacksResearch Dec. 18 at 4:39 PM
Pet insurance at adoption — smart distribution move by $MET 🐾📈 MetLife is expanding reach by embedding pet insurance into shelter adoptions through a Petstablished partnership, allowing adopters to bundle coverage into fees and protect pets from day one. See why this partnership could quietly scale adoption-driven growth 👉 https://www.zacks.com/stock/news/2806293/metlife-expands-pet-insurance-reach-through-petstablished-partnership?cid=sm-stocktwits-2-2806293-teaser-25447&ADID=SYND_STOCKTWITS_TWEET_2_2806293_TEASER_25447
0 · Reply
ZacksResearch
ZacksResearch Dec. 18 at 3:39 PM
$MET partners with Petstablished, integrating insurance into the adoption workflow 🐾📈 By easing pet owners' financial burdens early, MET aims to enhance customer engagement and gradually contribute to growth in specialty insurance sectors. Discover how this could impact MET’s growth strategy here 👉 https://www.zacks.com/stock/news/2806293/metlife-expands-pet-insurance-reach-through-petstablished-partnership?cid=sm-stocktwits-2-2806293-body-25437&ADID=SYND_STOCKTWITS_TWEET_2_2806293_BODY_25437
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 17 at 2:22 AM
$MET is currently trading at $82.47, with an RSI of 87.07 indicating it is overbought, suggesting a potential pullback. The 30-day MA is at $77.7, and the 50-day MA is at $78.59, both indicating bullish momentum but also highlighting a divergence with the current price. The 60-day high is $83.85, which presents a resistance level, while the low is $73.56, establishing a support base. Actionable Trade Alert: - Suggested Entry: $82.00 (slightly below current price) - Stop Loss: $80.50 (risking $1.50) - Take Profit Targets: 1. $84.00 (2.44% gain) 2. $85.50 (4.93% gain) 3. $96.50 (17% gain) Given the overbought RSI, a cautious approach is warranted. Monitor for price action near the 60D high. If the price breaks above $83.85, it could signal further upside potential. Trade Plan: Enter at $82.00, set stop at $80.50, and aim for targets at $84.00, $85.50, and $96.50. https://privateprofiteers.com
0 · Reply
ZacksResearch
ZacksResearch Dec. 16 at 5:43 PM
$BRK.B vs. $MET — which insurance giant really stands out right now? 🤔 Both remain resilient amid rate cuts and rising climate risks, but one is clearly outpacing the other on ROE and growth — and that gap matters for returns. See which insurer has the edge 👉 https://www.zacks.com/stock/news/2805187/berkshire-hathaway-vs-metlife-which-insurance-giant-stands-out?cid=sm-stocktwits-2-2805187-teaser-25089&ADID=SYND_STOCKTWITS_TWEET_2_2805187_TEASER_25089
0 · Reply
ZacksResearch
ZacksResearch Dec. 16 at 4:43 PM
$BRK.B vs. $MET: Which Insurance Giant Holds the Edge? 🤔 🔍 BRK.B sees a 3.5% revenue boost in 2025 but EPS down 5.2% year-over-year, despite a 6.7% EPS estimate rise recently. 🔍 MET shines with an 8.2% revenue increase and 7.2% EPS growth expected for 2025, though EPS estimates ticked down 0.1% lately. Discover the full investment case here 👉 https://www.zacks.com/stock/news/2805187/berkshire-hathaway-vs-metlife-which-insurance-giant-stands-out?cid=sm-stocktwits-2-2805187-body-25083&ADID=SYND_STOCKTWITS_TWEET_2_2805187_BODY_25083
0 · Reply
JarvisFlow
JarvisFlow Dec. 16 at 1:18 PM
Mizuho has adjusted their stance on MetLife ( $MET ), setting the rating to Outperform with a target price of 101.
0 · Reply
Latest News on MET
MetLife Preferreds Reviewed: Hold For Now

Nov 21, 2025, 8:00 AM EST - 4 weeks ago

MetLife Preferreds Reviewed: Hold For Now


MetLife Declares Fourth Quarter 2025 Preferred Stock Dividends

Nov 17, 2025, 4:15 PM EST - 5 weeks ago

MetLife Declares Fourth Quarter 2025 Preferred Stock Dividends


MetLife, Inc. (MET) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 12:36 PM EST - 6 weeks ago

MetLife, Inc. (MET) Q3 2025 Earnings Call Transcript


MetLife quarterly profit rises on investment gains

Nov 5, 2025, 6:00 PM EST - 7 weeks ago

MetLife quarterly profit rises on investment gains


MetLife Announces 3Q 2025 Results

Nov 5, 2025, 4:15 PM EST - 7 weeks ago

MetLife Announces 3Q 2025 Results


MetLife to Hold Conference Call for Third Quarter 2025 Results

Oct 8, 2025, 4:15 PM EDT - 2 months ago

MetLife to Hold Conference Call for Third Quarter 2025 Results


MetLife Declares Fourth Quarter 2025 Common Stock Dividend

Oct 7, 2025, 4:15 PM EDT - 2 months ago

MetLife Declares Fourth Quarter 2025 Common Stock Dividend


MetLife Announces Full Redemption of Series G Preferred Stock

Sep 2, 2025, 4:15 PM EDT - 4 months ago

MetLife Announces Full Redemption of Series G Preferred Stock


MetLife Declares Third Quarter 2025 Preferred Stock Dividends

Aug 15, 2025, 4:15 PM EDT - 4 months ago

MetLife Declares Third Quarter 2025 Preferred Stock Dividends


MetLife, Inc. (MET) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 3:04 PM EDT - 4 months ago

MetLife, Inc. (MET) Q2 2025 Earnings Call Transcript


MetLife's profit falls on less favorable underwriting margins

Aug 6, 2025, 6:50 PM EDT - 5 months ago

MetLife's profit falls on less favorable underwriting margins


MetLife Announces 2Q 2025 Results

Aug 6, 2025, 4:15 PM EDT - 5 months ago

MetLife Announces 2Q 2025 Results


Buy or Sell MetLife Stock Ahead of Earnings?

Aug 4, 2025, 6:35 AM EDT - 5 months ago

Buy or Sell MetLife Stock Ahead of Earnings?


MetLife Names Adrienne O'Neill as Chief Accounting Officer

Jul 30, 2025, 8:30 AM EDT - 5 months ago

MetLife Names Adrienne O'Neill as Chief Accounting Officer


MetLife to Hold Conference Call for Second Quarter 2025 Results

Jul 9, 2025, 4:15 PM EDT - 6 months ago

MetLife to Hold Conference Call for Second Quarter 2025 Results


The Best Financial Stocks to Buy

Jul 8, 2025, 4:59 PM EDT - 6 months ago

The Best Financial Stocks to Buy

BX CG


MetLife Declares Third Quarter 2025 Common Stock Dividend

Jul 8, 2025, 4:15 PM EDT - 6 months ago

MetLife Declares Third Quarter 2025 Common Stock Dividend


MetLife and Nayya Expand Access to Upwise via Workday Marketplace

Jun 23, 2025, 10:00 AM EDT - 6 months ago

MetLife and Nayya Expand Access to Upwise via Workday Marketplace


MetLife Investment Management Names Brian Funk President

Jun 18, 2025, 4:15 PM EDT - 6 months ago

MetLife Investment Management Names Brian Funk President


MetLife Names Jane Slusark as Chief Communications Officer

May 19, 2025, 1:01 PM EDT - 7 months ago

MetLife Names Jane Slusark as Chief Communications Officer


MetLife Declares Second Quarter 2025 Preferred Stock Dividends

May 15, 2025, 4:15 PM EDT - 7 months ago

MetLife Declares Second Quarter 2025 Preferred Stock Dividends


JediJumps
JediJumps Dec. 24 at 6:40 PM
$MET Long‑horizon outcomes depend on proof that pricing power can persist through normalization phases, with outcomes shaped by timing and discipline. Operational proof points remain decisive.
0 · Reply
JarvisFlow
JarvisFlow Dec. 23 at 2:37 PM
Wells Fargo updates rating for MetLife ( $MET ) to Overweight, target set at 92 → 94.
0 · Reply
1iquid
1iquid Dec. 20 at 12:05 PM
OptionWizards Tip (education only): Set a maximum loss for each options trade on D, PCAR, or MET to manage risk and protect your trading capital. $D $PCAR $MET Not financial advice.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 19 at 3:34 PM
$MET Actionable Trade Alert: Market Context: $MET is currently trading at $81.71, exhibiting strong bullish momentum with an RSI of 77.06, indicating overbought conditions. However, the price is near the 60D high of $83.85, suggesting potential resistance ahead. Directional Bias: The RSI indicates a strong bullish trend, but the proximity to the 60D high may lead to a pullback. The MA30 (77.88) and MA50 (78.57) provide support levels, indicating a potential for price correction before further upward movement. Trade Plan: - Suggested Entry: $81.00 (considering a slight pullback) - Stop Loss: $79.50 (2.5% below entry) - Take Profit Targets: 1. $83.00 (Target 1: 2.5% ROI) 2. $84.50 (Target 2: 4.5% ROI) 3. $95.00 (Target 3: 17% ROI) This trade plan allows for a calculated entry with a favorable risk-reward ratio. Monitor price action closely, especially around resistance levels. https://privateprofiteers.com
0 · Reply
ZacksResearch
ZacksResearch Dec. 18 at 4:39 PM
Pet insurance at adoption — smart distribution move by $MET 🐾📈 MetLife is expanding reach by embedding pet insurance into shelter adoptions through a Petstablished partnership, allowing adopters to bundle coverage into fees and protect pets from day one. See why this partnership could quietly scale adoption-driven growth 👉 https://www.zacks.com/stock/news/2806293/metlife-expands-pet-insurance-reach-through-petstablished-partnership?cid=sm-stocktwits-2-2806293-teaser-25447&ADID=SYND_STOCKTWITS_TWEET_2_2806293_TEASER_25447
0 · Reply
ZacksResearch
ZacksResearch Dec. 18 at 3:39 PM
$MET partners with Petstablished, integrating insurance into the adoption workflow 🐾📈 By easing pet owners' financial burdens early, MET aims to enhance customer engagement and gradually contribute to growth in specialty insurance sectors. Discover how this could impact MET’s growth strategy here 👉 https://www.zacks.com/stock/news/2806293/metlife-expands-pet-insurance-reach-through-petstablished-partnership?cid=sm-stocktwits-2-2806293-body-25437&ADID=SYND_STOCKTWITS_TWEET_2_2806293_BODY_25437
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 17 at 2:22 AM
$MET is currently trading at $82.47, with an RSI of 87.07 indicating it is overbought, suggesting a potential pullback. The 30-day MA is at $77.7, and the 50-day MA is at $78.59, both indicating bullish momentum but also highlighting a divergence with the current price. The 60-day high is $83.85, which presents a resistance level, while the low is $73.56, establishing a support base. Actionable Trade Alert: - Suggested Entry: $82.00 (slightly below current price) - Stop Loss: $80.50 (risking $1.50) - Take Profit Targets: 1. $84.00 (2.44% gain) 2. $85.50 (4.93% gain) 3. $96.50 (17% gain) Given the overbought RSI, a cautious approach is warranted. Monitor for price action near the 60D high. If the price breaks above $83.85, it could signal further upside potential. Trade Plan: Enter at $82.00, set stop at $80.50, and aim for targets at $84.00, $85.50, and $96.50. https://privateprofiteers.com
0 · Reply
ZacksResearch
ZacksResearch Dec. 16 at 5:43 PM
$BRK.B vs. $MET — which insurance giant really stands out right now? 🤔 Both remain resilient amid rate cuts and rising climate risks, but one is clearly outpacing the other on ROE and growth — and that gap matters for returns. See which insurer has the edge 👉 https://www.zacks.com/stock/news/2805187/berkshire-hathaway-vs-metlife-which-insurance-giant-stands-out?cid=sm-stocktwits-2-2805187-teaser-25089&ADID=SYND_STOCKTWITS_TWEET_2_2805187_TEASER_25089
0 · Reply
ZacksResearch
ZacksResearch Dec. 16 at 4:43 PM
$BRK.B vs. $MET: Which Insurance Giant Holds the Edge? 🤔 🔍 BRK.B sees a 3.5% revenue boost in 2025 but EPS down 5.2% year-over-year, despite a 6.7% EPS estimate rise recently. 🔍 MET shines with an 8.2% revenue increase and 7.2% EPS growth expected for 2025, though EPS estimates ticked down 0.1% lately. Discover the full investment case here 👉 https://www.zacks.com/stock/news/2805187/berkshire-hathaway-vs-metlife-which-insurance-giant-stands-out?cid=sm-stocktwits-2-2805187-body-25083&ADID=SYND_STOCKTWITS_TWEET_2_2805187_BODY_25083
0 · Reply
JarvisFlow
JarvisFlow Dec. 16 at 1:18 PM
Mizuho has adjusted their stance on MetLife ( $MET ), setting the rating to Outperform with a target price of 101.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 15 at 5:55 AM
$MET Actionable Trade Alert: Market Context: $MET is currently trading at $82.16, near its 60D high of $83.64, indicating strong bullish momentum. The RSI at 87.2 suggests that the asset is overbought, which may lead to a pullback or consolidation. However, the upward trend is supported by the MA30 at 77.6 and MA50 at 78.58, indicating a strong bullish bias. Directional Bias: The high RSI indicates potential overextension, but the proximity to the 60D high suggests that momentum could continue in the short term. Trade Plan: - Suggested Entry: $82.50 - Stop Loss: $80.50 (1.5 ATR below entry) - Take Profit Targets: 1. TP1: $84.00 (1.8% gain) 2. TP2: $86.00 (4.6% gain) 3. TP3: $96.00 (17% gain) This plan allows for a strong risk-reward ratio while accommodating potential volatility. Monitor closely for price action around the targets. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 11 at 10:48 PM
Actionable Trade Alert for $MET Market Context: $MET is currently trading at $81.88, showing strong bullish momentum as indicated by an RSI of 88.94, suggesting overbought conditions. The price is above both the 30-day MA (77.49) and the 50-day MA (78.56), reinforcing a bullish trend. The recent 60-day high is at $83.64, providing a resistance level. Directional Bias: The high RSI indicates potential for a pullback, but the overall trend remains bullish. The price is well above the recent low of $73.56, indicating strong buying interest. Suggested Trade Plan: - Entry: $81.88 - Stop Loss: $79.58 (2% below entry) - Take Profit Targets: 1. $83.00 (2% gain) 2. $84.50 (3.5% gain) 3. $96.00 (17% gain) This plan allows for a risk-reward ratio that accommodates a potential pullback while aiming for significant upside. Monitor RSI for signs of reversal. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 10 at 2:52 AM
Actionable Trade Alert for $MET: Market Context: $MET is currently trading at $77.81, showing strong momentum with an RSI of 65.97, indicating it's nearing overbought territory. The stock is above its 30-day moving average (MA30) of $77.33 but below the 50-day moving average (MA50) of $78.61, suggesting mixed signals. The recent 60-day high of $83.64 and low of $73.56 provide a clear range for potential movement. Directional Bias: Given the RSI nearing overbought and the proximity to MA50, the bias leans towards a potential pullback or consolidation before a breakout. However, the stock's current position suggests a bullish short-term outlook. Trade Plan: - Suggested Entry: $77.81 - Stop Loss: $75.50 (3% below entry) - Take Profit Targets: 1. $80.00 (2.8% gain) 2. $82.00 (5.6% gain) 3. $91.00 (16.5% gain) With these targets, the third take profit offers a potential ROI of over 17%. Monitor closely for price action. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 8 at 10:40 PM
Actionable Trade Alert for $MET: Market Context: $MET is currently trading at $78.17, showing strength as it approaches its 60D high of $83.64. The RSI at 67.79 indicates that the stock is nearing overbought territory, suggesting a potential pullback or consolidation. However, the price is above the 30-day moving average (MA30) of $77.37, indicating a bullish trend. Directional Bias: The price is above both the MA30 and MA50 (78.7), reinforcing a bullish outlook. The proximity to the 60D high suggests potential upward momentum, but caution is warranted due to the RSI level. Trade Plan: - Suggested Entry: $78.17 - Stop Loss: $76.91 (below the MA30) - Take Profit Targets: 1. $80.00 (2.33% gain) 2. $82.00 (4.66% gain) 3. $91.50 (17% gain) With the potential for a 17% ROI on the third target, this trade aligns well with current market conditions. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 1:40 AM
Actionable Trade Alert for $MET: Market Context: $MET is currently trading at $78.03, with a recent RSI of 42.97 indicating a neutral to slightly bearish momentum. The stock is positioned between its 60D high of $83.64 and low of $73.56, suggesting potential volatility. The 30-day moving average (MA30) is at $77.37, while the 50-day moving average (MA50) is slightly higher at $78.80, indicating a potential resistance area. Directional Bias: The RSI below 50 suggests a lack of bullish momentum, but the proximity to the MA30 indicates a possible reversal point. If the price breaks above the MA50, it could signal a bullish trend. Trade Plan: - Suggested Entry: $78.50 (above MA30) - Stop Loss: $76.50 (1.5 ATR below entry) - Take Profit Targets: - TP1: $80.00 (3.8% gain) - TP2: $82.00 (4.8% gain) - TP3: $91.50 (17.3% gain) This plan offers a risk-reward ratio that aligns with a strategic trading approach. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
Estimize
Estimize Dec. 4 at 2:00 PM
Wall St is expecting 2.36 EPS for $MET Q4 [Reporting 02/04 AMC] http://www.estimize.com/intro/met?chart=historical&metric_name=eps&utm_cont
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 1 at 6:20 PM
$MET Current Stock Price: $77.02 Contracts to trade: $80 MET Dec 19 2025 Call Entry: $0.45 Exit: $0.89 ROI: 98% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 28 at 9:51 AM
$MET Share Price: $76.32 Contract Selected: Mar 20, 2026 $80 Calls Buy Zone: $2.14 – $2.65 Target Zone: $3.48 – $4.25 Potential Upside: 53% ROI Time to Expiration: 111 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
SPYmyQQQ
SPYmyQQQ Nov. 25 at 10:57 PM
🎯 Target Hit 🏁 📨 From Nov 21, 2025 🏛️ $MET 💵 Entry: $74.2700 ✅ Exit: $76.3793 💰 P/L: +2.84% 👉 FREE TRIAL! spymyqqq/join/
0 · Reply
nikitatrades
nikitatrades Nov. 25 at 9:59 PM
Comparing $RAY.X vs $MET: Why I'm picking $MET 🚀 MET boasts significantly higher 24h trading volume ($158.5M vs $39.3M) and its innovative Dynamic Liquidity Market Maker (DLMM) tech offers superior capital efficiency for LPs. ✨ Meteora's recent (Oct 2025) token launch and rebrand from Mercurial (post-FTX) signals a fresh start with strong community ownership (48% circulating at TGE), injecting new growth potential. 📊 While $RAY.X holds a larger, more established market cap ($303.3M vs $159.7M) and a proven track record, $MET's advanced features and renewed momentum present a compelling case for future upside.
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 25 at 4:05 AM
$MET Share Price: $75.18 Contract Selected: Mar 20, 2026 $75 Calls Buy Zone: $3.57 – $4.41 Target Zone: $5.87 – $7.17 Potential Upside: 55% ROI Time to Expiration: 115 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
aby1
aby1 Nov. 24 at 11:18 PM
$NVDA $MET $GOOGL from X $META is reportedly in advanced talks to deploy $GOOGL TPUs across its data centers in a deal that could be worth billions & the real takeaway is the sheer scale of AI demand. Meta isn’t doing this to make a statement about $NVDA but because its internal AI workload growth is so aggressive that it needs every credible source of compute it can get.
0 · Reply